Self‐Expanding Aortic Endoprosthesis for Conduit Preparation Prior to Transcatheter Pulmonary Valve Replacement
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70039 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Kaitlyn Krebushevski and 4 co-authors. Institution: Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Heart Valve Prosthesis Implantation, Pulmonary Valve, Heart Valve Prosthesis, Blood Vessel Prosthesis Implantation. 12 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Preparation of the right ventricular outflow tract (RVOT) using covered stent placement is a common preparatory step for transcatheter pulmonary valve replacement (TPVR) to reduce the risk of disruption associated with dilating calcified RVOT conduits.
Aim
We present a novel method employing a self‐expanding covered aortic endoprosthesis and discuss its advantages as an alternative strategy.
Methods
Patients with congenital heart disease undergoing RVOT conduit preparation with the GORE TAG Thoracic Branch Endoprosthesis Extender (W.L. Gore & Associates, Newark, DE) followed by TPVR, were prospectively enrolled in a dedicated database. To date, 14 patients have been included. Data on demographics, diagnoses, procedural details, hemodynamic parameters, and outcomes were analyzed.
Results
Fourteen patients (median age: 35 years [range: 18–79]; 57% female) successfully underwent endograft placement immediately before TPVR. Treated conduits included pulmonary homografts ( n = 8), surgical bioprostheses ( n = 2), Hancock conduit ( n = 1), Contegra conduit ( n = 1), native RVOT ( n = 1), and Melody valve within a surgical bioprosthesis ( n = 1). Most patients presented with mixed stenosis and regurgitation ( n = 9), with the remaining having stenosis ( n = 4) or regurgitation ( n = 1). Valves implanted post‐preparation included the Sapien S3 valve (Edwards Lifesciences, Irvine, CA) ( n = 10) and the Melody valve (Medtronic, Minneapolis, MN) ( n = 5). Significant reductions in RVOT systolic gradient were observed (median 34 mmHg pre‐procedure to 3 mmHg post‐procedure), along with marked conduit expansion (median diameter 13 mm pre‐procedure to 25.5 mm post‐procedure). No complications were reported.
Conclusions
This study highlights the feasibility of a self‐expanding aortic endoprosthesis for RVOT preparation before TPVR. Further comparative study is warranted. Procedural success was achieved in all cases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine/Division of Structural Heart Diseases, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA.
ORCID profiles: Kaitlyn Krebushevski, Allison K Cabalka, Peter M Pollak, Liwei Yu, Jason H Anderson
Funding
- The authors received no specific funding for this work.
Cite
APA
Krebushevski, K., Cabalka, A. K., Pollak, P. M., Yu, L., & Anderson, J. H. (2025). Self‐Expanding Aortic Endoprosthesis for Conduit Preparation Prior to Transcatheter Pulmonary Valve Replacement. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70039
Vancouver
Krebushevski K, Cabalka AK, Pollak PM, Yu L, Anderson JH. Self‐Expanding Aortic Endoprosthesis for Conduit Preparation Prior to Transcatheter Pulmonary Valve Replacement. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70039
BibTeX
@article{Krebushevski2025,
author = {Krebushevski, Kaitlyn and Cabalka, Allison K and Pollak, Peter M and Yu, Liwei and Anderson, Jason H},
title = {Self‐Expanding Aortic Endoprosthesis for Conduit Preparation Prior to Transcatheter Pulmonary Valve Replacement},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70039}
}
EUVIMED